How to buy Mediclinic International (MDC) shares

Learn how to easily invest in Mediclinic International shares.

Mediclinic International plc (MDC) is a publicly traded medical care facilities business based in the UK. It opened the day at 296.46p after a previous close of 298p. During the day the price has varied from a low of 293.1826p to a high of 298p. The latest price was 294.6p (25 minute delay). Mediclinic International is listed on the London Stock Exchange (LSE) and employs 33,683 staff. All prices are listed in pence sterling.

How to buy shares in Mediclinic International

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: MDC in this case.
  5. Research Mediclinic International shares. The platform should provide the latest information available.
  6. Buy your Mediclinic International shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Fees for buying 100x Mediclinic International shares with popular platforms

Share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
eToro Free Stocks logo £0 $10 £0.00
£294.60 total
Capital at risk
IG Share Dealing logo £0 £250 £8.00
£302.60 total
Capital at risk
Fineco logo £0 No minimum £0.00
£294.60 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £11.95
£306.55 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £1.79
£296.39 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £7.99
£302.59 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £9.50
£304.10 total
Capital at risk

Full comparison of share dealing platforms

Mediclinic International share price (LSE:MDC)

Use our graph to track the performance of MDC stocks over time.

Mediclinic International price performance over time

Historical closes compared with the last close of 294.6p

1 week (2022-09-26) -40.07%
1 month (2022-09-02) -40.89%
3 months (2022-07-01) -35.00%
6 months (2022-03-31) -17.29%
2 years (2020-10-02) 2.08%
3 years (2019-10-03) -5.82%
5 years (2017-10-03) -54.43%

Is it a good time to buy Mediclinic International stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.

Promoted
IG bxs hero

Invest in Mediclinic International shares with IG

  • No commission on US shares
  • More than 13,000 shares to invest in
  • Open your account in minutes

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is Mediclinic International under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.

P/E ratio

Mediclinic International's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 25x. In other words, Mediclinic International shares trade at around 25x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

EBITDA

Mediclinic International's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £422 million.

The EBITDA is a measure of a Mediclinic International's overall financial performance and is widely used to measure a its profitability.

Environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Mediclinic International.

Total ESG risk score

Mediclinic International's total ESG risk: 22.08

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Mediclinic International's overall score of 22.08 (as at 01/01/2019) is pretty good – landing it in it in the 34th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Mediclinic International is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Environmental score

Mediclinic International's environmental score: 0.69/100

Mediclinic International's environmental score of 0.69 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that Mediclinic International is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Social score

Mediclinic International's social score: 11.99/100

Mediclinic International's social score of 11.99 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that Mediclinic International is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Governance score

Mediclinic International's governance score: 8.4/100

Mediclinic International's governance score puts it squarely in the 3rd percentile of companies rated in the same sector. That could suggest that Mediclinic International is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Controversy score

Mediclinic International's controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Mediclinic International scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Mediclinic International has, for the most part, managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Mediclinic International plc was last rated for ESG on: 2019-01-01.

Total ESG score 22.08
Total ESG percentile 33.76
Environmental score 0.69
Environmental score percentile 3
Social score 11.99
Social score percentile 3
Governance score 8.4
Governance score percentile 3
Level of controversy 2

Mediclinic International shares at a glance

Information last updated 2021-12-10.
Open296.46p
High298p
Low293.1826p
Close294.6p
Previous close298p
Change-3.4p
Change %-1.1409%
Volume385,190
Information last updated 2022-09-25.
52-week range284.6357p - 503.5p
50-day moving average492.74p
200-day moving average396.911p
Wall St. target price462.05p
PE ratio24.6
Dividend yield3p (0.61%)
Earnings per share (TTM)0.2p

Do Mediclinic International shares pay dividends?

0.6%

Dividend yield: 0.61% of stock value

0.6%

Forward annual dividend yield: 0.61% of stock value

14.3%

Dividend payout ratio: 14.29% of net profits

Mediclinic International has recently paid out dividends equivalent to 0.61% of its share value annually.

Mediclinic International has paid out, on average, around 14.29% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.61% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 0.61% return on their shares, in the form of dividend payments. In Mediclinic International's case, that would currently equate to about 3p per share.

While Mediclinic International's payout ratio might seem low, this can signify that the company is investing more in its future growth.

The latest dividend was paid out to all shareholders who bought their shares by 4 August 2022 (the "ex-dividend date").

Mediclinic International dividend history

Dividend Type Ex-dividend date Payment date
£0.032 Interim 05/12/2019 17/12/2019
£0.047 Final 13/06/2019 29/07/2019
£0.032 Interim 06/12/2018 18/12/2018
£0.047 Final 14/06/2018 30/07/2018
£0.032 Interim 07/12/2017 18/12/2017
£0.047 Final 22/06/2017 31/07/2017
£0.032 Interim 24/11/2016 12/12/2016
£0.0524 Final 16/06/2016 25/07/2016
£0.041 Interim 03/09/2015 05/10/2015
£0.09 Final 16/04/2015 15/05/2015
£0.037 Interim 10/09/2014 10/10/2014
£0.09 Final 12/03/2014 11/04/2014

Share price volatility

Over the last 12 months, Mediclinic International's shares have ranged in value from as little as 284.6357p up to 503.5p. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Mediclinic International's is 0.4564. This would suggest that Mediclinic International's shares are less volatile than average (for this exchange).

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site